Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Kidney concentrating capacity in children with autosomal recessive polycystic kidney disease is linked to glomerular filtration and hypertension

T. Seeman, K. Bláhová, F. Fencl, R. Klaus, B. Lange-Sperandio, G. Hrčková, Ĺ. Podracká

. 2023 ; 38 (7) : 2093-2100. [pub] 20221220

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23010963
E-zdroje Online Plný text

NLK ProQuest Central od 1996-08-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 1996-08-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 1996-08-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1996-08-01 do Před 1 rokem
Family Health Database (ProQuest) od 1996-08-01 do Před 1 rokem

BACKGROUND: Impaired kidney concentration capacity is present in half of the patients with autosomal dominant polycystic kidney disease (ADPKD). The kidney concentrating capacity was further impaired within the animal model of autosomal recessive polycystic kidney disease (ARPKD). To date, only one small study has investigated it in children having ARPKD. Therefore, we aimed to study the kidney concentrating ability in a larger cohort of children with ARPKD. METHODS: Eighteen children (median age 8.5 years, range 1.3-16.8) were retrospectively investigated. A standardized kidney concentrating capacity test was performed after the application of a nasal drop of desmopressin (urine osmolality > 900 mOsmol/kg). The glomerular filtration rate was estimated using the Schwartz formula (eGFR) and blood pressure (BP) was measured as office BP. RESULTS: Kidney concentrating capacity was decreased (urine osmolality < 900 mOsmol/kg) in 100% of children with ARPKD. The median urine osmolality after desmopressin application was 389 (range 235-601) mOsmol/kg. Sixteen patients (89%) were defined as hypertensive based on their actual BP level or their use of antihypertensive drugs. The maximum amounts of urinary concentration correlated significantly with eGFR (r = 0.72, p < 0.0001) and hypertensive scores (r = 0.50, p < 0.05), but not with kidney size. Twelve patients (67%) were defined as having CKD stages 2-4. The median concentrating capacity was significantly lower in children within this group, when compared to children with CKD stage 1 possessing a normal eGFR (544 mOsmol/kg, range 413-600 mOsmol/kg vs. 327 mOsmol/kg, range 235-417 mOsmol/l, p < 0.001). CONCLUSIONS: Impaired kidney concentrating capacity is present in most children with ARPKD and is associated with decreased eGFR and hypertension. A higher resolution version of the Graphical abstract is available as Supplementary information.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23010963
003      
CZ-PrNML
005      
20230801132731.0
007      
ta
008      
230718s2023 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00467-022-05834-5 $2 doi
035    __
$a (PubMed)36538056
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Seeman, Tomáš $u Department of Pediatrics, Dr. v. Hauner Children's Hospital, University Hospital, Ludwig Maximilian University Munich, Lindwurmstraße 4, 80337, Munich, Germany. tomas.seeman@med.uni-muenchen.de $u Department of Pediatrics, 2nd Medical Faculty, Charles University, Prague, Czech Republic. tomas.seeman@med.uni-muenchen.de $u Department of Pediatrics, University Hospital Ostrava, Ostrava, Czech Republic. tomas.seeman@med.uni-muenchen.de $1 https://orcid.org/0000000313713096
245    10
$a Kidney concentrating capacity in children with autosomal recessive polycystic kidney disease is linked to glomerular filtration and hypertension / $c T. Seeman, K. Bláhová, F. Fencl, R. Klaus, B. Lange-Sperandio, G. Hrčková, Ĺ. Podracká
520    9_
$a BACKGROUND: Impaired kidney concentration capacity is present in half of the patients with autosomal dominant polycystic kidney disease (ADPKD). The kidney concentrating capacity was further impaired within the animal model of autosomal recessive polycystic kidney disease (ARPKD). To date, only one small study has investigated it in children having ARPKD. Therefore, we aimed to study the kidney concentrating ability in a larger cohort of children with ARPKD. METHODS: Eighteen children (median age 8.5 years, range 1.3-16.8) were retrospectively investigated. A standardized kidney concentrating capacity test was performed after the application of a nasal drop of desmopressin (urine osmolality > 900 mOsmol/kg). The glomerular filtration rate was estimated using the Schwartz formula (eGFR) and blood pressure (BP) was measured as office BP. RESULTS: Kidney concentrating capacity was decreased (urine osmolality < 900 mOsmol/kg) in 100% of children with ARPKD. The median urine osmolality after desmopressin application was 389 (range 235-601) mOsmol/kg. Sixteen patients (89%) were defined as hypertensive based on their actual BP level or their use of antihypertensive drugs. The maximum amounts of urinary concentration correlated significantly with eGFR (r = 0.72, p < 0.0001) and hypertensive scores (r = 0.50, p < 0.05), but not with kidney size. Twelve patients (67%) were defined as having CKD stages 2-4. The median concentrating capacity was significantly lower in children within this group, when compared to children with CKD stage 1 possessing a normal eGFR (544 mOsmol/kg, range 413-600 mOsmol/kg vs. 327 mOsmol/kg, range 235-417 mOsmol/l, p < 0.001). CONCLUSIONS: Impaired kidney concentrating capacity is present in most children with ARPKD and is associated with decreased eGFR and hypertension. A higher resolution version of the Graphical abstract is available as Supplementary information.
650    _2
$a dítě $7 D002648
650    _2
$a lidé $7 D006801
650    12
$a polycystické ledviny autozomálně recesivní $x komplikace $7 D017044
650    _2
$a desmopresin $7 D003894
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a ledviny $7 D007668
650    12
$a hypertenze $7 D006973
650    12
$a polycystické ledviny autozomálně dominantní $7 D016891
650    _2
$a hodnoty glomerulární filtrace $7 D005919
650    12
$a chronická renální insuficience $x komplikace $7 D051436
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bláhová, Kveta $u Department of Pediatrics, 2nd Medical Faculty, Charles University, Prague, Czech Republic
700    1_
$a Fencl, Filip $u Department of Pediatrics, 2nd Medical Faculty, Charles University, Prague, Czech Republic
700    1_
$a Klaus, Richard $u Department of Pediatrics, Dr. v. Hauner Children's Hospital, University Hospital, Ludwig Maximilian University Munich, Lindwurmstraße 4, 80337, Munich, Germany $u Department of Pediatrics, 2nd Medical Faculty, Charles University, Prague, Czech Republic
700    1_
$a Lange-Sperandio, Bärbel $u Department of Pediatrics, Dr. v. Hauner Children's Hospital, University Hospital, Ludwig Maximilian University Munich, Lindwurmstraße 4, 80337, Munich, Germany
700    1_
$a Hrčková, Gabriela $u Department of Pediatrics, Medical Faculty, Comenius University and National Institute of Children's Diseases, Bratislava, Slovakia
700    1_
$a Podracká, Ĺudmila $u Department of Pediatrics, Medical Faculty, Comenius University and National Institute of Children's Diseases, Bratislava, Slovakia
773    0_
$w MED00003733 $t Pediatric nephrology (Berlin, Germany) $x 1432-198X $g Roč. 38, č. 7 (2023), s. 2093-2100
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36538056 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801132728 $b ABA008
999    __
$a ok $b bmc $g 1963409 $s 1197228
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 38 $c 7 $d 2093-2100 $e 20221220 $i 1432-198X $m Pediatric nephrology $n Pediatr Nephrol $x MED00003733
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...